CymaBay Therapeutics
CymaBay Therapeutics (CBAY) is a clinical-stage biopharmaceutical firm focused on improving the lives of people with liver and other chronic diseases that have a high unmet medical need through a pipeline of innovative therapies.
The firm is proud of its deep understanding of the underlying mechanisms of liver inflammation . . .
This content is for paid subscribers.
Impacting News
March 21, 2023